Free T3 Test: Drugs That Distort Your Results (and What Your Levels Mean)

What Free T3 Actually Measures (and Why It Matters More Than T3 Total)

Your thyroid produces mostly T4 (thyroxine), a storage hormone. To do anything useful, T4 must be converted into T3 (triiodothyronine), and only a tiny fraction of that T3 circulates unbound to carrier proteins. That unbound fraction is Free T3, the form your cells can actually take up and use. Total T3 includes protein-bound hormone that is metabolically inert, so Free T3 gives a more direct picture of thyroid activity at the cellular level.

The conversion from T4 to T3 happens mainly in the liver, kidneys, and skeletal muscle. It depends on enzymes called deiodinases, and this is exactly where drugs, illness, nutritional deficiencies, and hormonal changes intervene most dramatically.

Why Women Are Disproportionately Affected

Thyroid disease affects women five to eight times more often than men. Approximately one in eight women will develop a thyroid disorder during her lifetime. Women also take more medications that interfere with thyroid lab interpretation, including oral contraceptives, hormone therapy, biotin, and certain antidepressants. Because the reference ranges on most lab reports were established in populations that under-represented women across hormonal life stages, a result that looks "normal" on paper may be clinically misleading for you specifically.

The Free T3 Reference Range Explained

Most U.S. Labs report a Free T3 reference range of 2.3 to 4.2 pg/mL (approximately 3.5 to 6.5 pmol/L), but ranges shift by laboratory assay, by trimester in pregnancy, and by age. The American Association of Clinical Endocrinology (AACE) guidelines emphasize interpreting Free T3 alongside TSH and Free T4, never in isolation. A result sitting at the bottom of the reference range means something very different in a 28-year-old trying to conceive than in a 58-year-old postmenopausal woman on stable levothyroxine.

Drugs That Raise Free T3 (or Make It Look Higher Than It Is)

Several drug classes push Free T3 readings upward, either by increasing actual thyroid hormone production, blocking clearance, or interfering with the immunoassay itself.

Liothyronine (Synthetic T3)

This one is straightforward. If you take liothyronine (Cytomel) as part of a combination T4/T3 thyroid replacement regimen, your Free T3 will be elevated for two to four hours after dosing. Clinicians should draw your Free T3 sample before your morning dose, or results will be uninterpretable. Women on combination therapy for hypothyroidism often have their T3 levels flagged as high when the timing of the draw, not over-replacement, is the real problem.

Amiodarone (The Complex Case)

Amiodarone, an antiarrhythmic drug, does something counterintuitive: it initially raises Free T3 by blocking T3 clearance, then over weeks it substantially lowers Free T3 by inhibiting the enzyme (type-1 deiodinase) that converts T4 into T3. Amiodarone also contains 37% iodine by weight and directly inhibits thyroid hormone uptake into cells. The net effect on Free T3 depends entirely on how long the drug has been on board. In the first weeks, Free T3 may read high. After months of use, it typically falls well below normal even in a euthyroid person.

Heparin and Low-Molecular-Weight Heparins

Heparin and its derivatives displace thyroid hormones from binding proteins in the bloodstream, artificially elevating measured Free T3 and Free T4 in blood samples drawn within hours of IV or subcutaneous heparin administration. This is relevant for women hospitalized postpartum, those undergoing fertility treatments using injectable anticoagulation, and women with clotting disorders. If your thyroid labs were drawn while you were on heparin, the Free T3 result may be spuriously high.

Biotin (High-Dose Supplements)

Biotin (vitamin B7) at doses above 5 mg/day, commonly taken for hair loss or nail strength, interferes with the streptavidin-biotin immunoassay technology used by most modern labs. It can falsely raise Free T3, Free T4, and cause a falsely suppressed TSH, mimicking the pattern of hyperthyroidism. The FDA issued a safety communication on this in 2019. You should stop biotin for at least 48 to 72 hours before any thyroid panel. This is one of the most commonly missed distorters in women specifically, because high-dose biotin is marketed heavily to women for hair and nail concerns.

Oral Estrogen and Combination Oral Contraceptives

Oral estrogen, whether from combined oral contraceptives or menopausal hormone therapy taken by mouth, raises thyroid-binding globulin (TBG). More TBG means more T3 gets bound, which paradoxically lowers the free fraction available for measurement. In practice, your Free T3 on oral estrogen may read slightly lower rather than higher, but the total T3 rises. Women on levothyroxine who start oral estrogen often need a dose increase to maintain the same free hormone level. Transdermal estrogen (patch or gel) does not significantly raise TBG and therefore does not distort Free T3 measurements to the same degree.

Drugs That Lower Free T3 (or Make It Look Lower Than It Is)

This is a longer list. Many common medications suppress the conversion of T4 to T3 or accelerate clearance of thyroid hormones.

Glucocorticoids (Prednisone, Dexamethasone)

Glucocorticoids suppress pituitary TSH secretion and inhibit type-1 deiodinase, the enzyme that converts T4 to active T3 in peripheral tissues. Even short courses of prednisone at 20 mg/day or higher can suppress Free T3 by 20 to 30% within 24 hours, producing a pattern called euthyroid sick syndrome or low-T3 syndrome. Women taking corticosteroids for autoimmune conditions, asthma, or inflammatory bowel disease may have Free T3 results that falsely suggest hypothyroidism.

Beta-Blockers (Propranolol Most Notably)

Non-selective beta-blockers, particularly propranolol, inhibit the peripheral conversion of T4 to T3. Propranolol at doses of 160 to 240 mg/day has been shown to reduce Free T3 by approximately 15 to 25%. Selective beta-blockers (metoprolol, atenolol) have less impact on conversion, but the effect is not zero. This matters for women treated for thyrotoxicosis, where propranolol is sometimes used intentionally to drop T3 while waiting for definitive therapy, and for women on beta-blockers for hypertension or migraine prevention who have their thyroid labs evaluated at the same time.

Antiepileptic Drugs (Phenytoin, Carbamazepine, Phenobarbital)

These older antiepileptics induce hepatic CYP enzymes and accelerate the metabolism and clearance of thyroid hormones. Women on phenytoin or carbamazepine may show Free T3 values 15 to 30% below their true baseline, which is particularly important because women are more likely than men to be on antiepileptic drugs for conditions like epilepsy, bipolar disorder, or neuropathic pain. Newer antiepileptics (lamotrigine, levetiracetam) have much less effect on thyroid metabolism.

Lithium

Lithium blocks thyroid hormone release from the thyroid gland, reduces iodine uptake, and can cause hypothyroidism with a suppressed Free T3 over time. Up to 50% of people on long-term lithium develop subclinical hypothyroidism, and the rate is higher in women than men. Women with bipolar disorder on lithium should have Free T3 checked every six months, not just TSH, because the pattern of thyroid suppression can evolve over years.

Cholestyramine and Calcium / Magnesium Supplements

These don't alter your thyroid gland, but they bind levothyroxine in the gut and reduce its absorption, which over time lowers circulating Free T3 in women who are already on replacement therapy. Calcium carbonate, ferrous sulfate, and proton pump inhibitors have the same absorption-blocking effect. The AACE recommends separating levothyroxine from these agents by at least four hours.

Amiodarone (Long-Term Effect, Restated)

As noted above, the long-term effect of amiodarone is a substantial drop in Free T3. This is one drug where the direction of the lab distortion changes depending on duration of use. Women who have been on amiodarone for more than three months may have a Free T3 result that looks profoundly low, even if their tissues are not actually hypothyroid, because amiodarone also blocks intracellular T3 uptake.

Free T3 Across Your Hormonal Life Stages

No other thyroid marker shifts as consistently across reproductive life stages as Free T3. Understanding where you sit on this hormonal timeline changes how your clinician should interpret the number.

Reproductive Years and the Menstrual Cycle

Free T3 shows modest fluctuation across the menstrual cycle, with slightly higher values in the follicular phase when estrogen is rising. The clinical significance of within-cycle variation is debated, but studies published in Clinical Endocrinology have documented TSH and free thyroid hormone variation of up to 0.5 mIU/L for TSH across the cycle, which is enough to shift a borderline result from normal to abnormal depending on cycle timing.

Women with PCOS often have thyroid autoimmunity at higher rates than the general population, and both Hashimoto thyroiditis and PCOS are associated with insulin resistance that can further suppress deiodinase activity, lowering Free T3 even when TSH and Free T4 are technically in range. If you have PCOS and symptoms of hypothyroidism despite a "normal" TSH, asking specifically for Free T3 is clinically reasonable.

Trying to Conceive

Adequate Free T3 is necessary for follicular development and implantation. The American Thyroid Association's 2017 guidelines recommend a TSH below 2.5 mIU/L before conception, but they do not set a specific Free T3 target. Clinicians who specialize in reproductive endocrinology sometimes use Free T3 as an additional marker in women with recurrent pregnancy loss or unexplained infertility, particularly when TSH and Free T4 are borderline.

Pregnancy and Postpartum

Free T3 levels change substantially across pregnancy and require trimester-specific interpretation. In the first trimester, hCG stimulates the thyroid, pushing Free T3 upward relative to non-pregnant values. By the second and third trimesters, Free T3 falls to 1.8 to 3.1 pg/mL in many reference studies, well below the standard non-pregnant range, meaning a result that looks low by a general lab report may be entirely appropriate in pregnancy. Using a non-pregnant reference range in a second-trimester woman will over-diagnose hypothyroidism.

ACOG Practice Bulletin No. 223 on thyroid disease in pregnancy explicitly requires the use of trimester-specific or population-specific reference ranges for all thyroid hormones.

Postpartum thyroiditis affects five to ten percent of women in the year after delivery, and the hyperthyroid phase produces a temporarily elevated Free T3 that can be mistaken for Graves disease. This distinction matters because treatment differs: postpartum thyroiditis is usually self-limited and does not require antithyroid drugs.

Perimenopause and Menopause

Estrogen fluctuates dramatically in perimenopause, which means TBG levels are less stable than in the reproductive years. Free T3 results may vary more between draws for the same woman, and TSH-Free T3 discordance (where TSH looks normal but Free T3 is low) appears more frequently in this group. A 2020 analysis in Menopause found that thyroid autoimmunity peaks in the perimenopausal transition, increasing the likelihood of evolving hypothyroidism at exactly the time when fatigue, weight gain, and brain fog are also attributable to declining estrogen. Getting both thyroid and hormone panels drawn simultaneously makes clinical sense in this life stage.

Women on menopausal hormone therapy by mouth who also take levothyroxine typically need a levothyroxine dose increase of 25 to 50 mcg when starting oral estrogen, because elevated TBG lowers free hormone availability. Switching from oral to transdermal estrogen avoids this problem entirely.

Postmenopause

In postmenopause, the thyroid gland itself can develop nodular disease, and some benign nodules produce autonomous T3. A high Free T3 with a suppressed TSH in a postmenopausal woman warrants ultrasound and nuclear medicine evaluation, not just a medication review.

Pregnancy and Lactation Safety: Thyroid Drugs Affecting Free T3

This section covers the safety of medications commonly used to manage abnormal Free T3 levels during pregnancy and breastfeeding.

Levothyroxine in Pregnancy

Levothyroxine is safe throughout pregnancy. It is a Category A drug and remains the standard treatment for hypothyroidism. Dose requirements increase by approximately 30 to 50% during pregnancy, often beginning as early as the fourth to sixth week of gestation. The American Thyroid Association's 2017 guidelines recommend checking thyroid labs every four weeks during the first half of pregnancy to ensure Free T3 and Free T4 remain adequate.

Liothyronine in Pregnancy

Liothyronine crosses the placenta poorly. The evidence base for combination T4/T3 therapy in pregnancy is thin. ACOG and most reproductive endocrinologists recommend against using liothyronine alone or as the primary therapy during pregnancy, precisely because of this poor placental transfer. Levothyroxine remains the preferred treatment. If you are on combination therapy and become pregnant, discuss converting to levothyroxine-only with your clinician before conception if possible.

Antithyroid Drugs (Methimazole and Propylthiouracil) in Pregnancy

Both drugs lower Free T3 by reducing thyroid hormone synthesis. Propylthiouracil (PTU) also reduces Free T3 by blocking peripheral T4-to-T3 conversion, making it faster-acting in thyroid storm. PTU is preferred in the first trimester because methimazole carries a risk of a rare embryopathy including aplasia cutis and choanal atresia. After the first trimester, many clinicians switch to methimazole because PTU carries a small risk of maternal hepatotoxicity.

PTU does transfer into breast milk, but the American Thyroid Association considers doses up to 300 mg/day compatible with breastfeeding. Methimazole transfers at slightly higher rates but is also considered compatible at lower doses. Infant thyroid function should be monitored if the mother is on antithyroid therapy while breastfeeding.

Radioactive Iodine

Radioactive iodine (RAI) for hyperthyroidism is absolutely contraindicated in pregnancy and breastfeeding. It destroys the fetal or neonatal thyroid gland. ACOG explicitly states that RAI must not be used in pregnant women, and breastfeeding must be stopped and not restarted after RAI treatment. Women of reproductive age who receive RAI are advised to avoid pregnancy for at least six months post-treatment to allow normalization of thyroid levels and recovery of ovarian function.

Who Should Get Free T3 Tested (and Who Probably Does Not Need It)

Free T3 adds diagnostic value in specific clinical situations, but routine Free T3 screening in asymptomatic women is not supported by the AACE clinical practice guidelines or the Endocrine Society.

Free T3 is clinically appropriate for:

• Women on combination T4/T3 replacement who have persistent hypothyroid symptoms despite a normal TSH
• Women with suspected or confirmed hyperthyroidism where T3 toxicosis (high T3 with normal T4) is possible
• Women taking amiodarone, lithium, or antiepileptic drugs who have new thyroid symptoms
• Postpartum women with hyperthyroid symptoms to distinguish Graves disease from postpartum thyroiditis
• Women with recurrent pregnancy loss or unexplained infertility when other markers are borderline
• Perimenopausal women with fatigue and weight gain unresponsive to hormone therapy, where TSH-Free T3 discordance may explain residual symptoms

Free T3 is generally not needed for:

• Initial screening of healthy asymptomatic women
• Routine monitoring of stable hypothyroidism on levothyroxine-only therapy with a normal TSH
• Women whose symptoms are fully explained by another diagnosis

How to Get an Accurate Free T3 Result

Getting a meaningful Free T3 measurement requires attention to timing and preparation.

Before Your Draw

Stop biotin supplements (including multivitamins containing biotin above 0.3 mg) for at least 72 hours before the test. Tell your clinician if you are on heparin, high-dose biotin, or have received iodinated contrast recently.

Draw the sample in the morning, before taking any thyroid medication. For women on liothyronine, this is especially important: your Free T3 peaks within two to four hours of a dose, so drawing after your pill gives a spuriously high number.

Interpreting With Life Stage in Mind

Confirm that your lab report's reference range is appropriate for your situation. Pregnancy requires trimester-specific ranges. A postmenopausal woman on oral estrogen needs a clinician who understands that Free T3 may appear slightly lower due to elevated TBG, and that a small dose adjustment in levothyroxine rather than a misdiagnosis of worsening hypothyroidism may be the right response.

"A Free T3 result without context is nearly uninterpretable," says Dr. Elena Vasquez, WomanRx's board-certified OB-GYN reviewer. "I always want to know what day of the cycle the sample was drawn, what medications the patient is on, and whether she is pre- or postmenopausal before I assign meaning to the number."

What a High Free T3 Means for Women

A Free T3 above 4.2 pg/mL in a non-pregnant woman generally points toward excess thyroid hormone. The most common causes are:

• Graves disease: The most common cause of hyperthyroidism in women of reproductive age. Free T3 is often disproportionately elevated compared to Free T4 in Graves disease.
• T3 toxicosis: Free T3 is high but Free T4 is normal, seen in early Graves disease or in autonomously functioning thyroid nodules.
• Excessive thyroid hormone replacement: Particularly liothyronine or combination therapy.
• Drug distortion: Biotin, heparin, or early amiodarone exposure as described above.

High Free T3 accelerates bone turnover and increases fracture risk, lowers HDL cholesterol, and raises the risk of atrial fibrillation, which is disproportionately associated with thyroid hormone excess in women over 60.

What a Low Free T3 Means for Women

A Free T3 below 2.3 pg/mL in a non-pregnant adult woman can represent:

• True hypothyroidism: Most commonly Hashimoto thyroiditis, which affects women at a rate roughly 7:1 compared to men.
• Non-thyroidal illness (euthyroid sick syndrome): Serious illness, surgery, caloric restriction, or fasting all suppress deiodinase activity and drop Free T3 without any thyroid pathology. This is the body's metabolic downshift during stress, not a diagnosis that requires treatment.
• Drug-induced suppression: Glucocorticoids, beta-blockers, amiodarone (long-term), or antiepileptics as described above.
• Nutrient deficiencies: Selenium deficiency directly impairs deiodinase function. Selenoprotein-based deiodinase activity requires adequate selenium (55 mcg/day in adult women). Iron deficiency, more prevalent in premenopausal women, also reduces thyroid peroxidase activity.

Untreated hypothyroidism in reproductive-age women increases the risk of miscarriage, preterm birth, and impaired fetal neurodevelopment. The ATA's 2017 management guidelines assign levothyroxine treatment thresholds during pregnancy that are lower than outside of pregnancy.